opioid addiction

US court rejects Indivior’s appeal on Suboxone generic version
US court rejects Indivior’s appeal on Suboxone generic version
Pharmaceutical Business Review
Indivior
generics
Suboxone Film
Dr Reddy's
opioid addiction
Flag link:
Document: Facing blame for seeding the opioid crisis, Purdue explored its next profit opportunity — treating addiction
Document: Facing blame for seeding the opioid crisis, Purdue explored its next profit opportunity — treating addiction
Stat
Purdue Pharma
opioids
oxycontin
opioid crisis
opioid addiction
Flag link:
BioCorRx wins $5.6m grant for sustained release naltrexone implant
BioCorRx wins $5.6m grant for sustained release naltrexone implant
Drug Delivery Business News
devices
BioCorRx
NIH
naltrexone implant
opioid use disorder
opioid addiction
Flag link:
Indivior temporarily stops rival Alvogen's generic launch
Indivior temporarily stops rival Alvogen's generic launch
Reuters
Indivior
Alvogen
generics
opioid addiction
Suboxone
Flag link:
BioCentury - ‘Tentative’ FDA approval for Braeburn's opioid addiction product
BioCentury - ‘Tentative’ FDA approval for Braeburn's opioid addiction product
BioCentury
Braeburn Pharmaceuticals
FDA
Brixadi buprenorphine
opioid addiction
Flag link:
Purdue’s secret OxyContin papers should be released, appeals court rules
Purdue’s secret OxyContin papers should be released, appeals court rules
Stat
Purdue Pharma
oxycontin
opioid addiction
opioids
Flag link:
Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178
Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178
Stat
Kaleo
opioids
opioid addiction
generics
Naloxone
Evzio
opioid overdose
Flag link:
A drug maker boosted the price of its opioid-overdose antidote by 600 percent, and taxpayers suffered
A drug maker boosted the price of its opioid-overdose antidote by 600 percent, and taxpayers suffered
Stat
Naloxone
Kaleo
drug pricing
opioids
opioid addiction
Evzio
Flag link:
Senate Overwhelmingly Passes Bill to Address Prescription Opioids
Senate Overwhelmingly Passes Bill to Address Prescription Opioids
BioSpace
Senate
opioids
opioid addiction
Flag link:
Teva holding off launch of opioid addiction drug
Teva holding off launch of opioid addiction drug
Pharmaforum
Teva Pharmaceutical
opioids
opioid addiction
generics
Dr Reddy's
Suboxone
Indivior
Flag link:
Teva wins FDA nod for sublingual film to treat opioid dependence
Teva wins FDA nod for sublingual film to treat opioid dependence
Drug Delivery Business News
Teva Pharmaceutical
FDA
opioids
opioid addiction
Cassipa
sublingual treatments
Flag link:
Richard Sackler, member of family behind OxyContin, was granted patent for addiction treatment
Richard Sackler, member of family behind OxyContin, was granted patent for addiction treatment
Stat
Purdue Pharma
Dr. Richard Sackler
oxycontin
patent
opioid addiction
Flag link:
Alkermes in pay-for-performance deal
Alkermes in pay-for-performance deal
BioCentury
Alkermes
UPMC
Vivitrol
opioids
opioid addiction
pay-for-performance
Flag link:
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Reuters
Indivior
opioid addiction
generics
Suboxone Film
Dr Reddy's
Flag link:
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Reuters
Indivior
FDA
generics
Suboxone Film
opioids
opioid addiction
Flag link:
Origins of an Epidemic: Purdue Pharma Knew Its Opioids Were Widely Abused
Origins of an Epidemic: Purdue Pharma Knew Its Opioids Were Widely Abused
NY Times, NY
DOJ
Purdue Pharma
opioids
opioid addiction
opioid crisis
Flag link:
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
Suboxone Film
opioid addiction
Indivior
Flag link:
Trump opioid plan writes in favoritism to single company’s addiction medication
Trump opioid plan writes in favoritism to single company’s addiction medication
Stat
opioids
opioid crisis
opioid addiction
Donald Trump
Alkermes
Vivitrol
Flag link:
FDA wants to improve access to generic abuse-deterrent opioids: here’s how
FDA wants to improve access to generic abuse-deterrent opioids: here’s how
Drug Delivery Business News
FDA
generics
opioids
opioid addiction
abuse-resistant painkillers
Flag link:
FDA OKs behind-the-ear device for opioid withdrawal
FDA OKs behind-the-ear device for opioid withdrawal
Fierce Biotech
FDA
devices
opioid addiction
Innovative Health Solutions
NSS-2 Bridge
Flag link:

Pages